Follow the 株式会社ペルセウスプロテオミクス share price and the full directors' dealings record of the company, a listed issuer based in Japan. Shares trade on JP JP, under the authority of EDINET (Japan FSA). Operating in the Health Care sector, 株式会社ペルセウスプロテオミクス has logged 40 insider filings. Market capitalisation: €2.5bn. The latest transaction was filed on 3 July 2026 (Holding update). Among the most active insiders: SBI SECURITIES Co.,Ltd.. The full history is accessible without an account.
40
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
16Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 21,461 of 26,179 companies
29.2
score / 100
Value
9
Quality
50
FCF yld-25%
Earn yld-27%
EV/EBITDA·
ROE-54%
Gross mgn86%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Perseus Proteomics Co., Ltd. is a company specializing in proteomics, providing innovative solutions for health and pharmaceutical research. It is listed on the XTKS market.